Dynamics of cell-free tumour DNA correlate with treatment response of head and neck cancer patients receiving radiochemotherapy.

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
Franz J HilkeKerstin Clasen

Abstract

Definitive radiochemotherapy (RCTX) with curative intent is one of the standard treatment options in patients with locally advanced head and neck squamous cell carcinoma (HNSCC). Despite this intensive therapy protocol, disease recurrence remains an issue. Therefore, we tested the predictive capacity of liquid biopsies as a novel biomarker during RCTX in patients with HNSCC. We sequenced the tumour samples of 20 patients with locally advanced HNSCC to identify driver mutations. Subsequently, we performed a longitudinal analysis of circulating tumour DNA (ctDNA) dynamics during RCTX. Deep sequencing and UMI-based error suppression for the identification of driver mutations and HPV levels in the plasma enabled treatment-response monitoring prior, during and after RCTX. In 85% of all patients ctDNA was detectable, showing a significant correlation with the gross tumour volume (p-value 0.032). Additionally, the tumour allele fraction in the plasma was negatively correlated with the course of treatment (p-value <0.05). If ctDNA was detectable at the first follow-up, disease recurrence was seen later on. Circulating HPV DNA (cvDNA) could be detected in three patients at high levels, showing a similar dynamic behaviour to the ctDNA th...Continue Reading

References

Jun 11, 2004·The New England Journal of Medicine·Jin-Ching LinRong-San Jiang
May 19, 2009·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Jean-Pierre PignonUNKNOWN MACH-NC Collaborative Group
Dec 17, 2010·Nature Reviews. Cancer·C René LeemansRuud H Brakenhoff
Aug 28, 2015·Science Translational Medicine·Isaac Garcia-MurillasNicholas C Turner
Sep 19, 2015·Seminars in Radiation Oncology·Aadel A ChaudhuriMaximilian Diehn
Aug 3, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Liqiang XiMark Raffeld
Feb 25, 2017·Nature Reviews. Cancer·Jonathan C M WanNitzan Rosenfeld
Dec 3, 2017·Scientific Reports·Nidal MuhannaScott V Bratman
Dec 19, 2017·Archives of Pathology & Laboratory Medicine·James S LewisWilliam C Faquin
Mar 3, 2018·Nature Reviews. Cancer·C René LeemansRuud H Brakenhoff
Aug 12, 2018·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Kerstin ZwirnerChristopher Schroeder
Sep 11, 2018·Expert Review of Molecular Diagnostics·Ingeborg Tinhofer, Stephanie Staudte
Nov 9, 2018·Science Translational Medicine·Florent MouliereNitzan Rosenfeld
Apr 4, 2019·Molecular Diagnosis & Therapy·Re-I ChinAadel A Chaudhuri
May 7, 2019·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Emil ChristensenLars Dyrskjøt
May 28, 2019·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Kerstin ZwirnerStefan Welz
Jun 8, 2019·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·T EderUNKNOWN DKTK-ROG
Dec 20, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Shelize KhakooDavid Cunningham

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.